|Ignoring competing events in the analysis of survival data may lead to biased results: a nonmathematical illustration of competing risk analysis|
NA Schuster, EO Hoogendijk, AAL Kok, JWR Twisk, MW Heymans
Journal of clinical epidemiology 122, 42-48, 2020
|Frailty combined with loneliness or social isolation: an elevated risk for mortality in later life|
EO Hoogendijk, AP Smit, C van Dam, NA Schuster, S de Breij, ...
Journal of the American Geriatrics Society 68 (11), 2587-2593, 2020
|Intention-to-treat analysis when only a baseline value is available|
JWR Twisk, JJM Rijnhart, T Hoekstra, NA Schuster, MM Ter Wee, ...
Contemporary Clinical Trials Communications 20, 100684, 2020
|Predictors of Frailty and Vitality in Older Adults Aged 75 years and Over: Results from the Longitudinal Aging Study Amsterdam|
S de Breij, HPJ van Hout, SR De Bruin, NA Schuster, DJH Deeg, ...
Gerontology 67 (1), 69-77, 2021
|Accounting for time‐dependent treatment use when developing a prognostic model from observational data: A review of methods|
R Pajouheshnia, NA Schuster, RHH Groenwold, FH Rutten, KGM Moons, ...
Statistica Neerlandica 74 (1), 38-51, 2020
|Older adults report cancellation or avoidance of medical care during the COVID-19 pandemic: results from the Longitudinal Aging Study Amsterdam|
NA Schuster, S de Breij, LA Schaap, NM van Schoor, MJL Peters, ...
European Geriatric Medicine 12 (5), 1075-1083, 2021
|Noncollapsibility and its role in quantifying confounding bias in logistic regression|
NA Schuster, JWR Twisk, G Ter Riet, MW Heymans, JJM Rijnhart
BMC medical research methodology 21 (1), 1-9, 2021
|Explaining the association between frailty and mortality in older adults: The mediating role of lifestyle, social, psychological, cognitive, and physical factors|
S de Breij, JJM Rijnhart, NA Schuster, ML Rietman, MJL Peters, ...
Preventive medicine reports 24, 101589, 2021
|The Longitudinal Aging Study Amsterdam COVID-19 exposure index: a cross-sectional analysis of the impact of the pandemic on daily functioning of older adults|
EO Hoogendijk, NA Schuster, TG van Tilburg, LA Schaap, B Suanet, ...
|Methods to account for time-varying medication use when developing a model for patient prognosis|
R Pajouheshnia, N Schuster, R Groenwold, L Peelen
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 28, 232-232, 2019